Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v13-FR | Version v8-FR | |
---|---|---|
Language | French | French |
Date Updated | 2018-02-11 | 2017-03-13 |
Drug Identification Number | 02352044 | 02352044 |
Brand name | ADACEL-POLIO | ADACEL-POLIO |
Common or Proper name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine | ADACEL® POLIO |
Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
Ingredients | INACTIVATED POLIOMYELITIS VACCINE PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID FIMBRIAE TYPES 2 AND 3 INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE TETANUS TOXOID DIPHTHERIA TOXOID | INACTIVATED POLIOMYELITIS VACCINE PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID FIMBRIAE TYPES 2 AND 3 INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE TETANUS TOXOID DIPHTHERIA TOXOID |
Strength(s) | 8UNIT 3MCG 5MCG 2.5MCG 5MCG 32UNIT 40UNIT 5LF 2LF | 8UNIT 3MCG 5MCG 2.5MCG 5MCG 32UNIT 40UNIT 5LF 2LF |
Dosage form(s) | SUSPENSION | SUSPENSION |
Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
Packaging size | 10 x 0.5 mL syringes / 10 seringues de 0,5 mL | 10 x 0.5 mL syringes / 10 seringues de 0,5 mL |
ATC code | J07CA | J07CA |
ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED | BACTERIAL AND VIRAL VACCINES, COMBINED |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-06-22 | 2016-06-22 |
Actual start date | 2016-06-22 | 2016-06-22 |
Estimated end date | Unknown | Unknown |
Actual end date | 2018-02-01 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | The supply has been restored on February 01, 2018. | Supply disruptions are anticipated in the private market. Available supply will be dedicated primarily to publicly funded immunization programs and no disruption to these programs is expected. |
Health Canada comments |